Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
about
Emerging role of the brain in the homeostatic regulation of energy and glucose metabolismNutritional modulation of endogenous glucagon-like peptide-1 secretion: a reviewPeripheral signals mediate the beneficial effects of gastric surgery in obesityDecreased gastric mechanodetection, but preserved gastric emptying, in CCK-1 receptor-deficient OLETF ratsObesity: Current and potential pharmacotherapeutics and targets.Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery.Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects.Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans.Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in ratsEndogenous glucagon-like peptide-1 reduces drinking behavior and is differentially engaged by water and food intakes in rats.The vagus nerve, food intake and obesity.The role of incretins in glucose homeostasis and diabetes treatment.Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activationObesity surgery and gut-brain communication.Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputsRegulation of energy balance and body weight by the brain: a distributed system prone to disruption.Jejunal linoleic acid infusions require GLP-1 receptor signaling to inhibit food intake: implications for the effectiveness of Roux-en-Y gastric bypass.GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.TGR5 potentiates GLP-1 secretion in response to anionic exchange resins.Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese ratsDivergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats.Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4Gut hormones: the future of obesity treatment?Gut peptide signaling in the controls of food intake.Glucagon-like peptide-1 regulation of carbohydrate intake is differentially affected by obesogenic diets.Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.Role of peptide YY(3-36) in the satiety produced by gastric delivery of macronutrients in rats.Effects of solid-phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet-induced obese rats.Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypassStrategies for preventing type 2 diabetes: an update for clinicians.Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.CNS GLP-1 regulation of peripheral glucose homeostasis.Central and peripheral regulation of food intake and physical activity: pathways and genesEndogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signalingGlucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats.
P2860
Q26766494-3F6203BD-10BB-4D91-BA7A-58559C31C282Q28070256-6D0BF478-E612-4B09-BE47-177CDDD424CCQ28088425-9E26CC50-E6FA-4CC6-B0AF-2C62854E1AC0Q28564230-C6654004-7726-4301-9A94-7C2723E7B20AQ30243992-8760AE93-9C59-47B0-84AA-764470EA4E9CQ33772412-49FEFECE-D40B-45EA-9009-26EE524642BBQ33838133-CE570EE4-9BD8-4294-BF18-F51BFDB5343BQ34159708-04D9FBAA-9E35-40F5-8894-4F230707E7DAQ34225924-241DF54D-42D7-4BE5-9649-0F014E81910FQ34356012-9A69B535-857C-4AE8-892C-34554395AD97Q34614609-1C626B5D-79C7-4CC4-AC63-73EED15D78EDQ34778864-B7072111-1349-4C2B-8343-2855A1FFA86DQ34901533-47B5E8F4-DC60-4737-9947-7845F46EE18BQ35024826-7E2524C9-BCB2-4CD3-857E-FC8CB55D273AQ35054892-5C17CBA7-E954-42F7-AF3E-8330C550E045Q35110843-C9A052BA-261C-49D0-A5AC-204D114018E8Q35209811-C39E2237-03C4-4431-95B8-CCB1B7E83795Q35405459-6995D47E-D62D-4D62-87F2-D92142C04600Q35569563-4A5A0421-859B-4D53-8846-0B902D324825Q35601262-6B93CE26-CEEF-4045-820B-60A0F4506B19Q35744558-031CF480-9EC1-4F56-9AF1-38DF26E1647BQ35950315-C698FB93-BC74-48EE-98F5-AB16A364852BQ35996467-3C3E8FF5-8A73-4CAD-A402-7B218A5A090DQ36042116-59820821-DC58-4967-AD27-BCF81353135EQ36415844-F4157AC7-5BDC-4110-B9E0-F0548F2AA0A9Q36439654-B2A25A16-718A-4C18-AC33-F92A2F665C25Q36468102-29089EC7-5A14-468A-80F3-464DE5E57A0DQ36614364-51F26713-C41E-40B7-AFFC-0F999C0414B1Q36701866-33BA2B27-40F2-40A2-9ADC-2F855E82BA77Q36796571-49BC5059-E93A-4DCA-8353-3E645B10C3A4Q36836310-1FB6207F-CBBF-40EC-B5F9-54D5A959E559Q36949414-EB27C342-07C1-43BE-8BAD-AC4EF1339D18Q37100802-8BEA0904-CA41-4969-B0C4-9F8960807AD4Q37117608-FC6DF93D-0316-443D-80AF-751321F23E80Q37125945-144CD0CA-1D29-421B-A88C-5DA87A4933CFQ37136936-77F06A71-41E4-4A09-B1D0-D7BFD70768B2Q37174896-5F908177-7C72-42BE-AD73-81612BD1A2EFQ37204432-E3CD1E3A-1D44-43C7-BD8F-E083531FB174Q37210752-E2BAFC2A-B4C7-46AB-AB67-E2EFF966468DQ37224352-7C4CDA72-F59C-45B1-91C9-C33FF7AA89CD
P2860
Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Intravenous infusion of glucag ...... and gastric emptying in rats.
@en
Intravenous infusion of glucag ...... and gastric emptying in rats.
@nl
type
label
Intravenous infusion of glucag ...... and gastric emptying in rats.
@en
Intravenous infusion of glucag ...... and gastric emptying in rats.
@nl
prefLabel
Intravenous infusion of glucag ...... and gastric emptying in rats.
@en
Intravenous infusion of glucag ...... and gastric emptying in rats.
@nl
P2860
P1476
Intravenous infusion of glucag ...... , and gastric emptying in rats
@en
P2093
Alvin C Haver
Roger D Reidelberger
P2860
P304
P356
10.1152/AJPREGU.00870.2004
P577
2005-02-17T00:00:00Z